S. Collingwood

发表

Emerging therapies for respiratory diseases.

A. Ratcliffe, R. Lock, S. Collingwood, 2007, Drug news & perspectives.

Inhibition by viozan of extravasation induced in rat trachea by capsaicin is mediated exclusively by β2-adrenoceptors

J. Fozard, F. Baur, C. Wolber, 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.

Potentiating TMEM16A does not stimulate airway mucus secretion or bronchial and pulmonary arterial smooth muscle contraction

H. Danahay, M. Gosling, C. Ehre, 2020, FASEB bioAdvances.

Potentiating TMEM16A channel function has no effect on airway goblet cells or bronchial and pulmonary vascular smooth muscle function

H. Danahay, M. Gosling, C. Ehre, 2020, bioRxiv.

TMEM16A Potentiation: A Novel Therapeutic Approach for the Treatment of Cystic Fibrosis

H. Danahay, M. Gosling, J. Sabater, 2020, American journal of respiratory and critical care medicine.

ENaC‐mediated effects assessed by MRI in a rat model of hypertonic saline‐induced lung hydration

H. Danahay, N. Beckmann, F. Blé, 2010, British journal of pharmacology.

8‐Aryl Xanthines Potent Inhibitors of Phosphodiesterase 5.

S. Collingwood, 2003 .

8-Aryl xanthines potent inhibitors of phosphodiesterase 5.

Stephen P. Jelfs, M. Zurini, R. Naef, 2002, Bioorganic & medicinal chemistry letters.

Novel silicon-containing hydrocarbon rings and polymers via metathesis: X-ray crystal structure of cis,cis-1,1,6,6-tetraphenyl-1,6-disilacyclodeca-3,8-diene

W. Clegg, V. C. Gibson, S. Collingwood, 1991 .

Stereoselective syntheses of substituted succinic acid derivatives of the iron chiral auxiliary [(η5-C5H5)Fe(CO)(PPh3)]

J. E. Thomson, S. Davies, G. Bodwell, 2014 .

Potent and selective xanthine-based inhibitors of phosphodiesterase 5.

M. Zurini, R. Naef, S. Watson, 2007, Bioorganic & medicinal chemistry letters.

Solid-Phase Synthesis of Duocarmycin Analogues and the Effect of C-Terminal Substitution on Biological Activity.

M. O'Connell, H. Sheldrake, K. Fox, 2015, The Journal of organic chemistry.

Synthesis and duplex stability of oligodeoxyribonucleotides containing a 2′→5′-amide linkage

J. Arnold, J. Fisher, I. O'neil, 1999 .

Synthesis, structure and reactions of uridine2′-C,3′-O-γ-butyrolactone:versatile intermediate for the synthesis of 2′-C-branchednucleosides

A. Lawrence, J. Fisher, I. O'neil, 1997 .

Discovery of a novel chemotype of potent human ENaC blockers using a bioisostere approach. Part 1: quaternary amines.

Victoria L. Paddock, H. Danahay, P. Hunt, 2012, Bioorganic & medicinal chemistry letters.

Discovery of Icenticaftor (QBW251), a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator with Clinical Efficacy in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.

Paul J. Groot-Kormelink, D. Rowlands, H. Danahay, 2021, Journal of medicinal chemistry.

Optimization of Platelet-Derived Growth Factor Receptor (PDGFR) Inhibitors for Duration of Action, as an Inhaled Therapy for Lung Remodeling in Pulmonary Arterial Hypertension.

P. Furet, I. Konstantinova, A. Saunders, 2016, Journal of medicinal chemistry.

Comparing the cardiovascular therapeutic indices of glycopyrronium and tiotropium in an integrated rat pharmacokinetic, pharmacodynamic and safety model.

S. Charlton, D. Sykes, Kenny J. Watson, 2015, Toxicology and applied pharmacology.

Asymmetric synthesis of differentially protected α-alkyl succinates

S. Davies, G. Bashiardes, S. Collingwood, 1989 .

Therapeutic approaches towards the treatment of gastroinstestinal disorders.

J. Witherington, S. Collingwood, 2007, Drug news & perspectives.

NVP‐QBE170: an inhaled blocker of the epithelial sodium channel with a reduced potential to induce hyperkalaemia

Paul J. Groot-Kormelink, H. Danahay, P. Groot-Kormelink, 2015, British journal of pharmacology.